BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1095451)

  • 1. [Study of unheated filtrates of cultures of mycobacteria. III. Secies specificity of dialysable components of M. bovis (BCG-Poland) filtrates and M. kansasii].
    Komorowska-Rycerz A; Szczypiorska D; Grubek H; Michalska K; Zelechowska M
    Gruzlica; 1975 Jun; 43(6):543-52. PubMed ID: 1095451
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of unheated filtrates of cultures of mycobacteria. II. Isolation of catalase of the filtrate of cultures of BCG-Poland bacilli and its biological activity].
    Komorowska-Rycerz A; Michalska K; Szczyriorska D
    Gruzlica; 1975 Jun; 43(6):537-42. PubMed ID: 1095450
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of macrophage migration by a skin-reactive polysaccharide from BCG culture filtrates.
    Godfrey HP; Baer H; Chaparas SD
    J Immunol; 1969 Jun; 102(6):1466-73. PubMed ID: 4891552
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative study of immunizing and delayed hypersensitivity eliciting antigens of Mycobacterium leprae, M. tuberculosis, M. vaccae, and M. bovis (BCG).
    Sinha S; Sreevatsa ; Gupta SK; Sengupta U
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):42-53. PubMed ID: 2435824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of purified protein derivative extracts from cultures of mycobacteria killed by phenol.
    Choi CS; Frost AJ; Francis J
    Res Vet Sci; 1981 Nov; 31(3):284-8. PubMed ID: 7342222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the ability of protoplasm and culture filtrate (PPD) antigens from Mycobacterium tuberculosis, M. kansasii and M. batteyi to elicit delayed reactions in infected guinea pigs.
    Larson CL; Baker RE; Baker MB
    Am Rev Respir Dis; 1968 Dec; 98(6):1055-7. PubMed ID: 4972214
    [No Abstract]   [Full Text] [Related]  

  • 7. MPB70, a unique antigenic protein isolated from the culture filtrate of BCG substrain Tokyo.
    Nagai S; Miura K; Tokunaga T; Harboe M
    Dev Biol Stand; 1986; 58 ( Pt B)():511-6. PubMed ID: 3301461
    [No Abstract]   [Full Text] [Related]  

  • 8. [Purification, characterization and immunological study of 2 protein antigens of the BCG strain Mycobacterium bovis].
    De Bruyn J; Turneer M
    Bull Mem Acad R Med Belg; 1988; 143(1-2):157-70. PubMed ID: 3052672
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of unheated filtrates of Mycobacteria. Physico-chemical characteristics of culture filtrates of BCG-Poland substrate of various age].
    Michalska K; Komorowska-Rycerz A; Arczyńska E
    Gruzlica; 1974 Dec; 42(12):1177-82. PubMed ID: 4611855
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antigen L, a new antigen from tubercle bacilli active in delayed hypersensitivity in animals sensitized with living bacilli (B.C.G.)].
    Romain F; Augier-Gibory S; Versmisse E; Augier J
    C R Seances Acad Sci III; 1981 Nov; 293(11):631-3. PubMed ID: 6800581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria.
    Romain F; Laqueyrerie A; Militzer P; Pescher P; Chavarot P; Lagranderie M; Auregan G; Gheorghiu M; Marchal G
    Infect Immun; 1993 Feb; 61(2):742-50. PubMed ID: 8423100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic characterization of Mycobacterium bovis BCG soluble antigens.
    Gupta VK; Ram GC; Bansal MP
    Vet Microbiol; 1994 Jan; 38(3):227-40. PubMed ID: 8017027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic characterization of Mycobacterium bovis BCG culture filtrate.
    Gupta VK; Ram GC; Bansal MP
    Vet Microbiol; 1994 Aug; 41(4):345-53. PubMed ID: 7801534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative testing of the potency of different PPD preparations.
    Zsidai J; Joó I
    Dev Biol Stand; 1986; 58 ( Pt B)():599-605. PubMed ID: 3111905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of serologic and cell-mediated reactivity of a 38-kDa antigen isolated from Mycobacterium tuberculosis.
    Kadival GV; Chaparas SD; Hussong D
    J Immunol; 1987 Oct; 139(7):2447-51. PubMed ID: 2443566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic characterization of fractions of the BCG strain of M. bovis isolated by chromatofocusing].
    Nyabenda J; Pierre M; Keuterickx F; de Backer P
    Dev Biol Stand; 1986; 58 ( Pt A)():43-52. PubMed ID: 3297875
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of lymphocyte transformation, inhibition of macrophage migration and skin tests using dialyzable and nondialyzable tuberculin fractions from Mycobacterium bovis (BCG).
    Chaparas SD; Thor DE; Hedrick SR
    J Immunol; 1971 Jul; 107(1):149-53. PubMed ID: 4933403
    [No Abstract]   [Full Text] [Related]  

  • 19. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed type hypersensitivity and antituberculous immunity.
    Averbakh MM; Gergert VY; Kluyev VA; Kolodiazhnaya NS; Litvinsov VI; Moroz AM
    Z Immunitatsforsch Exp Klin Immunol; 1974 Aug; 147(3):204-16. PubMed ID: 4283014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.